Complete Filing Data
Churchill Capital Corp IX/Cayman reported Net Income Loss of $8.56 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Churchill Capital Corp IX/Cayman did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income Loss | $8.6M | $8.8M | -$19.0K |
| General And Administrative Expense | $3.9M | $830.8K | $19.0K |
| Operating Income Loss | -$3.9M | -$830.8K | -$19.0K |
| Nonoperating Income Expense | $12.5M | $9.6M | $0.00 |
| Operating Expenses | $0.00 | $44.0K | |
| General And Administrative Costs Paid By Through Promissory Note Related Party |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income Loss | $2.3M | $842.4K | $2.7M | $3.6M | $2.0M | -$24.1K |
| General And Administrative Expense | $915.9K | $2.3M | $283.5K | $257.9K | $298.2K | $24.1K |
| Operating Income Loss | -$915.9K | -$2.3M | -$283.5K | -$257.9K | -$298.2K | -$24.1K |
| Nonoperating Income Expense | $3.2M | $3.2M | $3.0M | $3.8M | $2.3M | $0.00 |
| Operating Expenses | $25.8K | |||||
| General And Administrative Costs Paid By Through Promissory Note Related Party | $25.8K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stockholders Equity | -$10.1M | -$7.1M | $6.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.5K | $2.4M | $0.00 |
| Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Common Stock | -$11.5M | -$24.5M | |
| Retained Earnings Accumulated Deficit | -$10.1M | -$7.1M | -$19.0K |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 |
| Liabilities And Stockholders Equity | $307.8M | $299.1M | $65.4K |
| Liabilities | $10.2M | $10.1M | $59.3K |
| Assets | $307.8M | $299.1M | $65.4K |
| Additional Paid In Capital Common Stock | $0.00 | $0.00 | $24.3K |
| Accrued Liabilities Current | $173.0K | $75.0K | $19.0K |
| Marketable Securities And Cash Held In Trust Account Noncurrent | $307.6M | $296.1M | $0.00 |
| Liabilities Current | $173.0K | $75.0K | $59.3K |
| Deferred Underwriting Fee Payable | $10.1M | $10.1M | $0.00 |
| Assets Current | $161.7K | $2.8M | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$2.4M | $2.4M | |
| Accrued Offering Costs Current | $0.00 | $2.9K | |
| Deferred Offering Costs Paid Through Promissory Note Related Party | $0.00 | $232.8K | $37.5K |
| Repayments Of Notes Payable | $0.00 | $314.3K | |
| Deferred Offering Costs Included In Accrued Offering Costs | $0.00 | $248.0K | $2.9K |
| Deferred Costs | $0.00 | $65.4K | |
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0.00 | 25.0K | 25.0K |
| Deferred Offering Costs | |||
| Deferred Offering Costs Included In Accrued Offerings Costs |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$9.7M | -$8.8M | -$7.4M | -$6.9M | -$6.6M | -$18.1K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $178.8K | $426.1K | $2.2M | $1.5M | $1.7M | $0.00 | |
| Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Common Stock | -$3.2M | -$2.2M | -$3.0M | -$3.8M | -$17.2M | ||
| Retained Earnings Accumulated Deficit | -$9.7M | -$8.8M | -$7.4M | -$6.9M | -$6.6M | -$43.1K | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Liabilities And Stockholders Equity | $305.0M | $303.2M | $301.9M | $295.8M | $292.3M | $229.2K | |
| Liabilities | $10.1M | $10.6M | $10.2M | $10.1M | $10.1M | $247.2K | |
| Assets | $305.0M | $303.2M | $301.9M | $295.8M | $292.3M | $229.2K | |
| Additional Paid In Capital Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $24.3K | |
| Accrued Liabilities Current | $81.2K | $544.6K | $117.9K | $75.0K | $76.7K | $17.2K | |
| Marketable Securities And Cash Held In Trust Account Noncurrent | $304.5M | $302.3M | $299.1M | $293.6M | $289.8M | ||
| Liabilities Current | $81.2K | $544.6K | $117.9K | $75.0K | $76.7K | ||
| Deferred Underwriting Fee Payable | $10.1M | $10.1M | $10.1M | $10.1M | $10.1M | ||
| Assets Current | $470.0K | $849.2K | $2.7M | $2.0M | $2.1M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$192.6K | $0.00 | |||||
| Accrued Offering Costs Current | $0.00 | $0.00 | $21.3K | ||||
| Deferred Offering Costs Paid Through Promissory Note Related Party | $145.4K | ||||||
| Repayments Of Notes Payable | |||||||
| Deferred Offering Costs Included In Accrued Offering Costs | $18.4K | ||||||
| Deferred Costs | $0.00 | $0.00 | |||||
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | |||||||
| Deferred Offering Costs | $229.2K | $65.4K | |||||
| Deferred Offering Costs Included In Accrued Offerings Costs | $18.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Increase Decrease In Accrued Liabilities | $98.0K | $56.0K | $19.0K |
| Net Cash Provided By Used In Operating Activities | -$3.4M | -$1.3M | |
| Increase Decrease In Prepaid Insurance | -$431.0K | $583.0K | |
| Increase Decrease In Prepaid Expenses Other | $1.0K | $6.2K | |
| Net Cash Provided By Used In Investing Activities | $1.0M | -$286.5M | |
| Payments For Underwriting Expense | $0.00 | $10.1M | $25.0K |
| Net Cash Provided By Used In Financing Activities | $0.00 | $290.2M | |
| Payments Of Stock Issuance Costs | $262.0K | ||
| Proceeds From Sale Of Units Net | $0.00 | $281.8M | |
| Proceeds From Sale Of Private Placement Units | $0.00 | $7.3M | |
| Payments To Acquire Restricted Investments | $0.00 | $287.5M | |
| Proceeds From Sale Of Restricted Investments | $1.0M | $1.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Increase Decrease In Accrued Liabilities | $42.9K | -$1.7K |
| Net Cash Provided By Used In Operating Activities | -$192.6K | $0.00 |
| Increase Decrease In Prepaid Insurance | -$107.7K | |
| Increase Decrease In Prepaid Expenses Other | $59.8K | |
| Net Cash Provided By Used In Investing Activities | ||
| Payments For Underwriting Expense | ||
| Net Cash Provided By Used In Financing Activities | ||
| Payments Of Stock Issuance Costs | ||
| Proceeds From Sale Of Units Net | ||
| Proceeds From Sale Of Private Placement Units | ||
| Payments To Acquire Restricted Investments | ||
| Proceeds From Sale Of Restricted Investments |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Sale Of Stock Number Of Shares Issued In Transaction | 287.5M | ||
| Weighted Average Number Of Shares Outstanding Basic | |||
| Weighted Average Number Of Diluted Shares Outstanding | |||
| Earnings Per Share Diluted | |||
| Earnings Per Share Basic |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Sale Of Stock Number Of Shares Issued In Transaction | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 6.3M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 6.3M | |||||
| Earnings Per Share Diluted | $0.00 | |||||
| Earnings Per Share Basic | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Investment Income Interest | $12.5M | $9.6M | $0.00 |
| Prepaid Insurance Non Current | $0.00 | $152.0K | $0.00 |
| Prepaid Expense Current | $7.2K | $6.2K | $0.00 |
| Prepaid Insurance Current | $152.0K | $431.0K | $0.00 |
| Underwriters Reimbursement | $0.00 | $1.8M | |
| Adjustments To Additional Paid In Capital Warrant Issued | $1.4M | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $86.4K | ||
| Adjustments To Additional Paid In Capital Private Placement Units | $7.3M | ||
| Stock Issued During Period Value New Issues | $25.0K | ||
| Adjustments To Additional Paid In Capital Other | $7.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Investment Income Interest | $3.2M | $3.2M | $3.0M | $3.8M | $2.3M | $0.00 |
| Prepaid Insurance Non Current | $0.00 | $0.00 | $44.3K | $259.8K | $367.5K | |
| Prepaid Expense Current | $31.4K | $55.6K | $66.0K | $12.4K | $42.2K | |
| Prepaid Insurance Current | $259.8K | $367.5K | $431.0K | $431.0K | $431.0K | |
| Underwriters Reimbursement | ||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $1.4M | |||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $86.4K | |||||
| Adjustments To Additional Paid In Capital Private Placement Units | $7.3M | |||||
| Stock Issued During Period Value New Issues | ||||||
| Adjustments To Additional Paid In Capital Other | $7.3M |
Most recent annual filing with the SEC: February 5, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.